Aug 14, 2025, 08:03

American Cancer Society (ACS) EDS Accelerator Award

One-year commercialization grant to validate and de-risk ongoing cancer research with a clear plan toward licensing or startup; not for initiating new projects. Up to 75,000 USD; no indirect costs.

Eligibility Criteria:

Independent PI with full-time faculty (or equivalent) at a US not-for-profit institution.
Commercialization plan required; one PI (no co-PIs); scientific overlap with other funding not allowed.
Host must provide appropriate research compliance and infrastructure.

Funding Details:

Up to USD 75,000 total for 1 year; no indirect costs; monthly institutional payments.

Deadline:

Rolling submission via ProposalCentral; you have 1 month to submit after starting an application; decisions typically within 12 months.

Where to Go for Further Information:

Apply on ProposalCentral; program contact: [email protected]; ACS policies and instructions available in the EDS Accelerator materials.

ACS American Cancer Society cancer commercialization grant EDS Accelerator licensing strategy OncoDaily Oncology Proof of Concept proposalCENTRAL research funding startup readiness technology transfer translational research

IMvigor011 Trial Reports ctDNA as Predictor of Response to Adjuvant Atezolizumab in Bladder Cancer

Ruben Mesa is Starting a New Position as President of Cancer National Service Line at Advocate Health

Patrick Soon-Shiong: 30 Years and $3B Toward a Universal Cancer Fighter

Dana Dornsife: After 19 Years, Lazarex Cancer Foundation Is Shuttering Because of Lack of Funding

Matt Sherer: ASCO Supports Permanent Medicare Telehealth